Novo Nordisk A/S, Denmark
Charis Segeritz-Walko is Director of Innovation Projects for Novo Nordisk’s Cell Therapy R&D department. In this role, she oversees the exploration and evaluation of new project ideas and partnerships, and their maturation into Novo Nordisk’s early project portfolio. She previously contributed as a Principal Scientist to Novo Nordisk’s department for Global Drug Development by establishing advanced human in vitro models for drug target discovery and validation. Prior to joining Novo Nordisk, Charis lead a R&D team at STEMCELL Technologies, advancing products for stem cell differentiation from ideation to market launch. Charis holds a Ph.D. in stem cell biology and regenerative medicine from the University of Cambridge.
PROGRESSING CELL THERAPIES TO CLINIC: UNDERSTANDING THE CELLULAR DRUG PRODUCT
Friday, July 12, 2024
8:15 AM – 9:45 AM CEST